Sign up to receive our daily health newsletter

Latest health news

  • FDA will review Fosamax, Boniva for safety

    11/03/2010

    The Food and Drug Administration said [on] Wednesday it's conducting a safety review of certain bone-building drugs like Fosamax and Boniva to see if they increase the risk of femur fractures.

  • FDA rejects Actelion's Zavesca for rare NP-C disease

    11/03/2010

    Actelion’s bid to get a new use approved for Gaucher disease drug Zavesca has suffered a setback after regulators in the USA asked more information on the drug as a treatment for a rarer condition.

  • FDA panel backs InterMune's Esbriet for IPF

    11/03/2010

    Shares in InterMune will soar today after advisors to the US Food and Drug Administration voted in favour of recommending Esbriet for approval as a treatment for lung scarring.

  • C&W wins diabetes work

    11/03/2010

    Merck Sharp & Dohme has selected Cohn & Wolfe to handle the PR for its type two diabetes treatment, Januvia, after a competitive pitch. The brief is believed to be worth £1m and will be headed by C&W's London healthcare team.

  • Porter Novelli snares former Hill & Knowlton healthcare boss Shipra

    11/03/2010

    Porter Novelli has signed former Hill & Knowlton healthcare chief Shipra Singh to head its EMEA healthcare business.